CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for KBG Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

KBG Corp
84-19, Daeheungsindeok-gil
Seongnam-myeon, Dongnam-gu
Phone: +82 415236201p:+82 415236201 Cheonan, 31248  South Korea Ticker: 318000318000

Business Summary
KBG Corp, formerly Korea Bio-Gen Co Ltd, is a Korea-based company mainly engaged in silicone materials business. The Company manufactures and sells silicone materials such as silane monomers, silicone resins and polymers, and silicone fusion materials. The Company also produces and sell fine chemicals and bio products.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202412/31/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Executive Officer, Director Sam YeolBu 35 3/23/2023 3/24/2022

General Information
Number of Employees: 68 (As of 6/30/2024)
Outstanding Shares: 8,699,361 (As of 9/30/2024)
Shareholders: 13,919
Stock Exchange: KDQ
Fax Number: +82 415236203


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024